1Anthonisen NR,Manfreda J,Warren CPW,et al.Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease[J].Ann Intern Med,1987,106 (2):196 -204.
2Celli BR,MacNee W,Agusti A,et al.Standards for diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper[J].Eur Respir J,2004,23 (6):932-946.
3Burge S,Wedzicha JA.COPD exacerbations:definitions and classifications[J].Eur Respir J,2003,41 (Suppl):46-53.
4Global Initiative for Chronic Obstructive Pulmonary Disease.Global strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease,Executive Summary[EB/OL].Available at:www.goldcopd.com.2005.
5Sethi S,Evans N,Grant B,et al.New strains of bacteria and exacerbations of chronic obstructive pulmonary disease[J].N Engl J Med,2002,347:465-471.
7Singh JM,Palda VA,Stanbrook MB,et al.Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease:a systematic review[J].Arch Intern Med,2002,162 (12):2527-2536.
8Maltais F,Ostinali J,Bourbeau J,et al.Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease:a randomized controlled trial[J].Am J Respir Crit Care Med,2002,165:698-703.
9Keenan SP,Gregor J,Sibbald WJ,et al.Noninvasive positive pressure ventilation in the setting of severe,acute exacerbations of chronic obstructive pulmonary disease:more effective and less expensive[J].Crit Care Med,2000,28:2094-2102.
10Miller LG,Goldstein G,Murphy M,et al.Reversible alterations in immunoregulatory T cells in smoking.Analysis by monoclonal antibodies and flow cytometry.Chest,1982,82:526-529.
